Brief: Neovacs Secures Financing From French National Research Agency
Jan 8 (Reuters) - NEOVACS SA ALNEV.PA :
* REG-NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH
NATIONAL
RESEARCH AGENCY - TO DEVELOP THE IL-4/IL-13 KINOID AS AN ALLERGY
TREATMENT
* FINANCING TO DEVELOP IL-4/IL-13 KINOID AS AN ALLERGY
TREATMENT
* AGREEMENT BETWEEN NEOVACS AND ANR PROVIDES EUR 702,000 IN
FUNDING,
Source text for Eikon: urn:newsml:reuters.com:*:nGNEccXvd
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants